Health Canada reinstates CannTrust’s Vaughan licences

CannTrust Holdings says Health Canada has reinstated the pot producer’s licences at its Vaughan, Ont. manufacturing facility. Last August, the regulator found CannTrust broke several rules, including insufficient security controls and areas constructed without regulatory approval. "Our licence reinstatement is the result of an enormous amount of hard work by the CannTrust team," CEO Greg Guyatt said in a release Thursday. "Today marks the beginning of the next chapter in CannTrust's history.” The company said it will restart manufacturing at its Vaughan facility imminently and that it expects to have products available in the fourth-quarter of this year. In May, Health Canada reinstated the licence for its Fenwick, Ont. facility, nearly a year after inspectors first discovered marijuana grown in unlicensed rooms.

Cronos reports Q2 loss, officially enters Israeli market

Toronto-based cannabis producer Cronos Group announced a second-quarter loss of $3 million on Thursday, hampered by a $3.1-million inventory writedown it blamed on industry price compression. Net revenue checked in at $9.9 million, a $2.2-million bump from the same period in 2019. Cronos also announced that it has launched a medical line of dried flower in Israel under the name Peace Naturals. The company also issued an update on how the COVID-19 pandemic has impacted business, stating that while it has ‘sufficient inventory,’ unplanned closures at the manufacturing or vendor level could cause a supply-chain disruption.

Girls' Night Out is getting into the cannabis game

The company behind popular Girls' Night Out wine is getting into the cannabis business. Ontario-based Colio Estate Wines announced Thursday a supply agreement with Natural MedCo Ltd., the wholly-owned subsidiary of Eve & Co., for an initial three-year period to create cannabis-infused beverages. The chief executive of Eve & Co. said the company is excited to work with the team behind the Girls’ Night Out brand, noting it allows them to "provide consumers with a new cannabis-infused beverage which aligns very well with our female-oriented vision.”  

TerrAscend reports high U.S. sales growth in preliminary results release

Ontario-based cannabis company TerrAscend Corp. is releasing preliminary financial results for its second quarter. The company said Thursday its U.S. business generated 90 per cent of its net sales, boosting total revenue by 36 per cent year-over-year to $47.2 million. “Our strong top and bottom-line performance reflects our unwavering commitment to achieve best-in-class results from our operations,” said Jason Ackerman, CEO and executive chairman of TerrAscend. “With cultivation at our New Jersey production facility underway and our Pennsylvania operations continuing to track ahead of plan, I am confident we can continue this solid momentum into the second half of the year.” The company will post its final second-quarter results Aug. 20.

Sign up for BNN Bloomberg's new weekly newsletter, Home Economics, which aims to help Canadians navigate their personal finances in the age of social distancing and beyond. Have it delivered to your inbox every Friday by subscribing at





-- The average additional monthly amount baby boomers and millennials are spending on cannabis during the pandemic, according to a study from Verilife, a dispensary operator owned by Chicago-based PharmaCann

Embedded Image

Cannabis Canada is BNN Bloomberg’s in-depth series exploring the ongoing growth of the Canadian recreational cannabis industry. Read more here and subscribe to our Cannabis Canada newsletter to have the latest news delivered directly to your inbox every day.